Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum

Journal of Virology

Volumn 79, Issue 3, 2005, Pages 1351-1360

  Chandhasin, Chandtip ^a,b   Coan, Patricia N ^a   Levy, Laura S ^a,b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HISTIDINE; MEMBRANE PROTEIN; PROLINE; GLYCOPROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CAT; CONTROLLED STUDY; ECOTROPIC VIRUS; ENVELOPE GENE; FELINE LEUKEMIA VIRUS; FIBROBLAST; GENE SEQUENCE; HORIZONTAL GENE TRANSFER; HOST RANGE; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROVIRUS; SEQUENCE ANALYSIS; SUPERINFECTION; THYMUS LYMPHOMA; VIRUS STRAIN; ANIMAL; CAT DISEASE; CELL LINE; DNA SEQUENCE; DOG; FEMALE; GENETICS; HUMAN; LYMPHOMA; METABOLISM; MOLECULAR GENETICS; MUTATION; PATHOGENICITY; PATHOPHYSIOLOGY; RETROVIRUS INFECTION; T CELL LYMPHOMA; THYMOMA; THYMUS; VIROLOGY; VIRUS INFECTION;

ANIMALS; CAT DISEASES; CATS; CELL LINE; DOGS; FEMALE; GLYCOPROTEINS; HUMANS; LEUKEMIA VIRUS, FELINE; LYMPHOMA; LYMPHOMA, T-CELL; MOLECULAR SEQUENCE DATA; MUTATION; RETROVIRIDAE INFECTIONS; SEQUENCE ANALYSIS, DNA; THYMUS GLAND; THYMUS NEOPLASMS; TUMOR VIRUS INFECTIONS; VIRAL ENVELOPE PROTEINS;

EID: 13744258584     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.3.1351-1360.2005     Document Type: Article

References (43)

1. Anderson, M. M., A. S. Lauring, C. C. Burns, and J. Overbaugh. 2000. Identification of a cellular cofactor required for infection by feline leukemia virus. Science 287:1828-1830.
2. Athas, G. B., B. Choi, S. Prabhu, P. A. Lobelle-Rich, and L. S. Levy. 1995. Genetic determinants of feline leukemia virus-induced multicentric lymphomas. Virology 214:431-438.
3. Athas, G. B., P. Lobelle-Rich, and L. S. Levy. 1995. Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors. J. Virol. 69:3324-3332.
4. Bae, Y., S. M. Kingsman, and A. J. Kingsman. 1997. Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J. Virol. 71:2092-2099.
5. Battini, J. L., J. M. Heard, and O. Danos. 1992. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J. Virol. 66:1468-1475.
6. Boomer, S., M. Eiden, C. C. Burns, and J. Overbaugh. 1997. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition. J. Virol. 71:8116-8123.
7. Brojatsch, J., B. S. Kristal, G. A. Viglianti, R. Khiroya, E. A. Hoover, and J. I. Mullins. 1992. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein. Proc. Natl. Acad. Sci. USA 89:8457-8461.
8. Chandhasin, C., P. A. Lobelle-Rich, and L. S. Levy. 2004. Feline leukemia virus LTR variation and disease association in a geographic and temporal cluster. J. Gen. Virol. 85:2937-2942.
9. Chen, H., M. K. Bechtel, Y. Shi, A. Phipps, L. E. Mathes, K. A. Hayes, and P. Roy-Burman. 1998. Pathogenicity induced by feline leukemia virus, Rickard strain, subgroup A plasmid DNA (pFRA). J. Virol. 72:7048-7056.
10. Cotter, S. M. 1992. Feline leukemia virus: pathophysiology, prevention, and treatment. Cancer Investig. 10:173-181.
11. Donahue, P. R., E. A. Hoover, G. A. Beltz, N. Riedel, V. M. Hirsch, J. Overbaugh, and J. I. Mullins. 1988. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62:722-731.
12. Donahue, P. R., S. L. Quackenbush, M. V. Gallo, C. M. deNoronha, J. Overbaugh, E. A. Hoover, and J. I. Mullins. 1991. Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J. Virol. 65:4461-4469.
13. Farrell, K. B., Y. T. Ting, and M. V. Eiden. 2002. Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins. J. Virol. 76:4267-4274.
14. Finstad, S. L., S. Prabhu, K. R. Rulli, and L. S. Levy. 2004. Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR. Virol. J. 1:3.
15. Gwynn, S. R., F. C. Hankenson, A. S. Lauring, J. L. Rohn, and J. Overbaugh. 2000. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains. J. Virol. 74:5754-5761.
16. Hedrick, S. M., D. I. Cohen, E. A. Nielsen, and M. M. Davis. 1984. Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature 308:149-153.
17. Hoover, E. A., and J. I. Mullins. 1991. Feline leukemia virus infection and diseases. J. Am. Vet. Med. Assoc. 199:1287-1297.
18. Kavanaugh, M. P., D. G. Miller, W. Zhang, W. Law, S. L. Kozak, D. Kabat, and A. D. Miller. 1994. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA 91:7071-7075.
19. Kristal, B. S., T. A. Reinhart, E. A. Hoover, and J. I. Mullins. 1993. Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins. J. Virol. 67:4142-4153.
20. Lauring, A. S., M. M. Anderson, and J. Overbaugh. 2001. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants. J. Virol. 75:8888-8898.
21. Lauring, A. S., H. H. Cheng, M. V. Eiden, and J. Overbaugh. 2002. Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection. J. Virol. 76:8069-8078.
22. Lavillette, D., A. Ruggieri, S. J. Russell, and F. L. Cosset. 2000. Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. J. Virol. 74:295-304.
23. Levesque, K. S., L. Bonham, and L. S. Levy. 1990. flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type. J. Virol. 64:3455-3462.
24. Neil, J. C., R. Fulton, M. Rigby, and M. Stewart. 1991. Feline leukaemia virus: generation of pathogenic and oncogenic variants. Curr. Top. Microbiol. Immunol. 171:67-93.
25. Nunberg, J. H., M. E. Williams, and M. A. Innis. 1984. Nucleotide sequences of the envelope genes of two isolates of feline leukemia virus subgroup B. J. Virol. 49:629-632.
26. Olah, Z., C. Lehel, W. B. Anderson, M. V. Eiden, and C. A. Wilson. 1994. The cellular receptor for gibbon ape leukemia virus is a novel high affinity sodium-dependent phosphate transporter. J. Biol. Chem. 269:25426-25431.
27. Overbaugh, J., and C. R. Bangham. 2001. Selection forces and constraints on retroviral sequence variation. Science 292:1106-1109.
28. Overbaugh, J., P. R. Donahue, S. L. Quackenbush, E. A. Hoover, and J. I. Mullins. 1988. Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science 239:906-910.
29. Prabhu, S., P. A. Lobelle-Rich, and L. S. Levy. 1999. The FeLV-945 LTR confers a replicative advantage dependent on the presence of a tandem triplication. Virology 263:460-470.
30. Quigley, J. G., C. C. Burns, M. M. Anderson, E. D. Lynch, K. M. Sabo, J. Overbaugh, and J. L. Abkowitz. 2000. Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. Blood 95:1093-1099.
31. Rezanka, L. J., J. L. Rojko, and J. C. Neil. 1992. Feline leukemia virus: pathogenesis of neoplastic disease. Cancer Investig. 10:371-389.
32. Riedel, N., E. A. Hoover, P. W. Gasper, M. O. Nicolson, and J. I. Mullins. 1986. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J. Virol. 60:242-250.
33. Rohn, J. L., M. L. Linenberger, E. A. Hoover, and J. Overbaugh. 1994. Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors. J. Virol. 68:2458-2467.
34. Rohn, J. L., M. S. Moser, S. R. Gwynn, D. N. Baldwin, and J. Overbaugh. 1998. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant. J. Virol. 72:2686-2696.
35. Rojko, J. L., G. J. Kociba, J. L. Abkowitz, K. L. Hamilton, W. D. Hardy, Jr., J. N. Ihle, and S. J. O'Brien. 1989. Feline lymphomas: immunological and cytochemical characterization. Cancer Res. 49:345-351.
36. Roy-Burman, P. 1996. Endogenous env elements: partners in generation of pathogenic feline leukemia viruses. Virus Genes 11:147-161.
37. Stewart, M. A., M. Warnock, A. Wheeler, N. Wilkie, J. I. Mullins, D. E. Onions, and J. C. Neil. 1986. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J. Virol. 58:825-834.
38. Sugai, J., M. Eiden, M. M. Anderson, N. Van Hoeven, C. D. Meiering, and J. Overbaugh. 2001. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2. J. Virol. 75:6841-6849.
39. Tailor, C. S., and D. Kabat. 1997. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains. J. Virol. 71:9383-9391.
40. Tailor, C. S., B. J. Willett, and D. Kabat. 1999. A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J. Virol. 73:6500-6505.
41. Takeuchi, Y., R. G. Vile, G. Simpson, B. O'Hara, M. K. Collins, and R. A. Weiss. 1992. Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J. Virol. 66:1219-1222.
42. Wensel, D. L., W. Li, and J. M. Cunningham. 2003. A virus-virus interaction circumvents the virus receptor requirement for infection by pathogenic retroviruses. J. Virol. 77:3460-3469.
43. Zavorotinskaya, T., Z. Qian, J. Franks, and L. M. Albritton. 2004. A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion. J. Virol. 78:473-481.